Osanni Bio closes $190 million Series B financing led by Patient Square Capital to advance its innovative pipeline in ophthalmology and cardiology.
Amount Raised
$190 Million
Round Type
Series B
San FranciscoBiotechnologyHealth CareTherapeuticsInvestors
Description
Osanni Bio LLC has announced the close of a $190 million Series B financing led by Patient Square Capital. The financing proceeds will be used to advance the company's current pipeline and enhance its discovery and development process. Existing investors also participated in the round. Osanni aims to leverage modern technology for efficient medicine discovery.
Quick answer
Osanni Bio raised $190 Million in a Series B round, dated June 23, 2026. Investors: Invus Opportunities, Retinal Degeneration Fund, Horowitz Group and Patient Square Capital. Osanni Bio is based in San Francisco, California, United States.
- How much did Osanni Bio raise?
- Osanni Bio raised $190 Million in a Series B round on June 23, 2026.
- Who invested in Osanni Bio?
- Invus Opportunities, Retinal Degeneration Fund, Horowitz Group and Patient Square Capital are named as investors in this round.
- What does Osanni Bio do?
- Osanni Bio is a development-stage therapeutics platform focused on reinventing the discovery and development of new medicines.
- Where is Osanni Bio based and how big is it?
- Osanni Bio is based in San Francisco, California, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Osanni Bio that raised within 45 days of this round, from Fundz verified event records.
- Opal Therapeutics raised $1.3M (Grant) on August 7, 2026.
- Tarsus Pharmaceuticals raised $125M (Post-IPO Equity) on August 6, 2026.
- Expedition raised $115M (Series B) on August 5, 2026.
- Acasti raised $10M on August 4, 2026.
- GentiBio raised $1.2M (Grant) on August 2, 2026.
- Ratio Therapeutics raised $70M (Series C) on July 31, 2026.
Who to call at Osanni Bio, and when
A new round usually means Osanni Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Osanni Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Osanni Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Osanni Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Osanni Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansOsanni Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.